Cancer and thromboembolic disease: pathogenic mechanisms
- 1 June 2002
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 28 (3) , 137-140
- https://doi.org/10.1016/s0305-7372(02)00044-0
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Update on Tumor Cell Procoagulant FactorsActa Haematologica, 2001
- Molecular Basis for the Relationship Between Thrombosis and CancerThrombosis Research, 2001
- Changes of the Coagulation and Fibrinolysis System in Malignancy: Their possible Impact on Future Diagnostic and Therapeutic Procedurescclm, 2000
- Thrombotic Complications of Central Venous Catheters in Cancer PatientsSeminars in Thrombosis and Hemostasis, 1999
- The Thrombophilic State Induced by Therapeutic Agents in the Cancer PatientSeminars in Thrombosis and Hemostasis, 1999
- Inhibition of Metastases by AnticoagulantsJNCI Journal of the National Cancer Institute, 1999
- Cancer Procoagulant and Tissue Factor Are Differently Modulated by All-trans-Retinoic Acid in Acute Promyelocytic Leukemia CellsBlood, 1998
- HYPERCOAGULABILITY IN CANCERHematology/Oncology Clinics of North America, 1996
- Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humansBlood, 1989